Literature DB >> 26691607

The burden of serious human fungal infections in Brazil.

Juliana Giacomazzi1, Ludmila Baethgen1, Lilian C Carneiro1, Maria Adelaide Millington2, David W Denning3, Arnaldo L Colombo4, Alessandro C Pasqualotto1,5.   

Abstract

In Brazil, human fungal infections are prevalent, however, these conditions are not officially reportable diseases. To estimate the burden of serious fungal diseases in 1 year in Brazil, based on available data and published literature. Historical official data from fungal diseases were collected from Brazilian Unified Health System Informatics Department (DATASUS). For fungal diseases for which no official data were available, assumptions of frequencies were made by estimating based on published literature. The incidence (/1000) of hospital admissions for coccidioidomycosis was 7.12; for histoplasmosis, 2.19; and for paracoccidioidomycosis, 7.99. The estimated number of cryptococcal meningoencephalitis cases was 6832. Also, there were 4115 cases of Pneumocystis pneumonia in AIDS patients per year, 1 010 465 aspergillosis and 2 981 416 cases of serious Candida infections, including invasive and non-invasive diseases. In this study, we demonstrate that more than 3.8 million individuals in Brazil may be suffering from serious fungal infections, mostly patients with malignant cancers, transplant recipients, asthma, previous tuberculosis, HIV infection and those living in endemic areas for truly pathogenic fungi. The scientific community and the governmental agencies should work in close collaboration in order to reduce the burden of such complex, difficult-to-diagnose and hard to treat diseases.
© 2015 Blackwell Verlag GmbH.

Entities:  

Keywords:  Brazilian fungal burden; Fungal infections; epidemiology; mycology

Mesh:

Year:  2015        PMID: 26691607     DOI: 10.1111/myc.12427

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  36 in total

1.  Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.

Authors:  Leighann Sherry; Ryan Kean; Emily McKloud; Lindsay E O'Donnell; Rebecca Metcalfe; Brian L Jones; Gordon Ramage
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Serious fungal infections in Peru.

Authors:  B Bustamante; D W Denning; P E Campos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-10       Impact factor: 3.267

3.  Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.

Authors:  Sheena Mukkada; Jeannette Kirby; Nopporn Apiwattanakul; Randall T Hayden; Miguela A Caniza
Journal:  Curr Clin Microbiol Rep       Date:  2016-04-18

4.  Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.

Authors:  Clara E Negri; Sarah S Gonçalves; Ana Cristina P Sousa; Maria Daniela Bergamasco; Marinês D V Martino; Flavio Queiroz-Telles; Valerio Rodrigues Aquino; Paulo de Tarso O Castro; Ferry Hagen; Jacques F Meis; Arnaldo L Colombo
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  The Frequency of Natural Killer Cell Subsets in Patients with Acquired Immune Deficiency Syndrome with Deep Fungal Infections.

Authors:  Gao Chen; Chun-Jun Qin; Meng-Zheng Wu; Fei-Fei Liu; Shu-Shu Liu; Li Liu
Journal:  Infect Drug Resist       Date:  2021-02-09       Impact factor: 4.003

Review 6.  Immune Response to Coccidioidomycosis and the Development of a Vaccine.

Authors:  Natalia Castro-Lopez; Chiung-Yu Hung
Journal:  Microorganisms       Date:  2017-03-16

7.  Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017.

Authors:  Helmut J F Salzer; Rhett J Stoney; Kristina M Angelo; Thierry Rolling; Martin P Grobusch; Michael Libman; Rogelio López-Vélez; Alexandre Duvignaud; Hilmir Ásgeirsson; Clara Crespillo-Andújar; Eli Schwartz; Philippe Gautret; Emmanuel Bottieau; Sabine Jordan; Christoph Lange; Davidson H Hamer
Journal:  J Travel Med       Date:  2018-08-01       Impact factor: 8.490

8.  Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.

Authors:  Hazael Hernandez; Victor H Erives; Luis R Martinez
Journal:  Curr Trop Med Rep       Date:  2019-06-14

Review 9.  Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.

Authors:  Felix Bongomin; Sara Gago; Rita O Oladele; David W Denning
Journal:  J Fungi (Basel)       Date:  2017-10-18

10.  Laryngeal paracoccidioidomycosis presenting as solitary true vocal fold disease.

Authors:  Walter de Araujo Eyer-Silva; Annelise Callmann Santana; Guilherme Almeida Rosa da Silva; Marcelo Costa Velho Mendes de Azevedo; Juliana Li Ting Matos Sun Barreto; Marina Apolloni Neumann; Izana Junqueira de Castro; Rodrigo Panno Basílio-de-Oliveira; Luciana Ferreira de Araujo; Nathane Zanineli Ré; Felipe Marques de Oliveira; Caio José de Araujo Simas; Marcos André de Sarvat; Fernando Raphael de Almeida Ferry
Journal:  IDCases       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.